dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
Published 5 years ago • 542 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
3:06
titan trial
-
0:54
kim chi, md, regarding the titan study presented at asco 2019
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
6:42
titan trial
-
1:17
dr. chi discusses the latitude study in metastatic prostate cancer
-
1:38
kim n. chi, md, regarding key highlights from the final analysis of the phase iii titan study
-
1:34
dr. chi on abiraterone versus enzalutamide for metastatic castration-resistant prostate cancer
-
0:54
apalutamide combination is well tolerated in metastatic castration-sensitive prostate cancer
-
1:26
dr. burgess on key data in metastatic castration-sensitive prostate cancer
-
3:28
apalutamide and the titan clinical trial
-
1:50
dr. agarwal on pfs2 data from the titan trial in mcspc
-
1:37
dr. agarwal on drug development in metastatic castration-sensitive prostate cancer
-
5:48
data for metastatic castration-sensitive prostate cancer
-
2:28
dr. yu on treatment intensification in metastatic castration-sensitive prostate cancer
-
0:55
dr. chi on the importance of ctdna in mcrpc
-
2:22
dr. hwang on treatment selection in metastatic castration-sensitive prostate cancer
-
13:05
titan: update on the data and where next for patients with hormone sensitive pc
-
1:20
nancy a. dawson, md, discusses outcomes from the titan study in mcspc